CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 30 filers reported holding CARDIOME PHARMA CORP in Q3 2015. The put-call ratio across all filers is 4.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $20,000 | -4.8% | 2,500 | 0.0% | 0.00% | – |
| Q3 2015 | $21,000 | -12.5% | 2,500 | 0.0% | 0.00% | – |
| Q2 2015 | $24,000 | +4.3% | 2,500 | 0.0% | 0.00% | – |
| Q1 2015 | $23,000 | 0.0% | 2,500 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $23,000 | +4.5% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $22,000 | +10.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $20,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $20,000 | +233.3% | 2,500 | +150.0% | 0.00% | – |
| Q4 2013 | $6,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 528,913 | $1,227,000 | 0.00% |